USE OF MUCOKINETIC DRUGS IN THE TREATMENT OF DISEASES OF THE UPPER RESPIRATORY TRACT AND EARS

Inflammatory diseases of the upper respiratory tract and ears are prevalent and often lead to complications due to increased mucus viscosity and impaired mucociliary clearance. While mucokinetic drugs are commonly used, the efficacy of herbal secretolytics like Sunipran remains underexplored. This study examines the impact of Sunipran in treating acute rhinosinusitis through a comparative clinical trial involving two patient groups. One group received standard treatment, while the other was additionally administered Sunipran. Findings revealed that Sunipran significantly reduced nasal congestion, improved mucus clearance, and expedited recovery compared to conventional therapy alone. These results highlight the potential of Sunipran as an effective, non-antibiotic alternative for respiratory infections, emphasizing its role in reducing antibiotic use and enhancing treatment outcomes.